Latvia vs Netherlands: Proportion of bloodstream infection due to methicillin-resistant
Latvia
3.0%
in 2023
Netherlands
1.4%
in 2023
Latvia rank
51st
Netherlands rank
54th
Proportion of bloodstream infection due to methicillin-resistant over time
- Latvia
- Netherlands
How they compare
Latvia currently reports 3.0% against 1.4% in Netherlands, a difference of 1.6%.
That makes Latvia's figure about 2.1 times Netherlands's.
Across all 7 years both countries report, Latvia has been ahead every year.
Latvia ranks 51st and Netherlands ranks 54th of 55 countries.
Latvia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Latvia | Netherlands | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.6% | 1.4% | 5.1% | Latvia |
| 2020s | 6.3% | 1.7% | 4.5% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of bloodstream infection due to methicillin-resistant, Latvia or Netherlands?
- Latvia, at 3.0% against 1.4% in Netherlands as of 2023.
- What is the difference in proportion of bloodstream infection due to methicillin-resistant between Latvia and Netherlands?
- 1.6%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Netherlands?
- 7 years are reported by both, from 2017 to 2023.
- How do Latvia and Netherlands rank globally for proportion of bloodstream infection due to methicillin-resistant?
- Latvia ranks 51st and Netherlands ranks 54th of 55 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.